Lymph node transfer proven effective for lymphedema after breast cancer surgery

Japan­ese drug­mak­er Ono Phar­ma­ceu­ti­cal is ac­quir­ing can­cer-fo­cused biotech De­ci­phera Phar­ma­ceu­ti­cals for $2.4 bil­lion, the com­pa­nies an­nounced Mon­day morn­ing. The deal will see Ono ac­quire all

Sea­soned biotech CEO Deb­o­rah Dun­sire is re­tir­ing from Lund­beck af­ter five years, mak­ing room for Charl van Zyl to step in as pres­i­dent and CEO